Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Published:2004-12 Issue:6 Volume:14 Page:457-470
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Detke Michael J.,Wiltse Curtis G.,Mallinckrodt Craig H.,McNamara Robert K.,Demitrack Mark A.,Bitter Istvan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference78 articles.

1. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability;Anderson;J. Affect. Disord,2000

2. The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature;Ansari;Harv. Rev. Psychiatry,2000

3. New standard of depression treatment: remission and full recovery;Bakish;J. Clin. Psychiatry,2001

4. Hypochondriasis. An evaluation of the DSM-III criteria in medical outpatients;Barsky;Arch. Gen. Psychiatry,1986

5. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis;Beasley;Clin. Ther,2000

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine;Frontiers in Psychiatry;2024-06-13

2. Effects of Antidepressants on Sleep in Post-traumatic Stress Disorder: An Overview of Reviews;Current Neuropharmacology;2024-04

3. Practical pathway for the management of depression in the workplace: a Canadian perspective;Frontiers in Psychiatry;2023-09-05

4. A Comprehensive Review on the Neuropharmacological Effects of Antidepressants in Various Prospects;Current Psychopharmacology;2023-08-07

5. A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder;Journal of Affective Disorders;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3